Attendance Space Filling Up at Medtech Insight's 'Investment In Innovation' Emerging Medical Technology Conference, San Francisco, June 8-9, 2004.

Business Editors/Health/Medical Writers

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--April 28, 2004

Medtech Insight, LLC has announced that it will host close to 60 early-stage medical technology companies and 400 senior executives from the leading healthcare investment firms and medical device companies at its 11th "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference, being held June 8-9, 2004, at The Palace Hotel in San Francisco. Attendance space is filling up fast for this premier event; through Friday, April 30 only, attendees registering for the conference can save $200 off the $1,395 registration fee.

Medtech Insight is a leading provider of business information on emerging technologies, companies and market opportunities in the medical device industry. The company's In3 conferences bring together small emerging medical technology companies, venture capitalists, investment bankers, and corporate business development executives for funding, acquisition, and/or strategic partnership opportunities.

"The response to our upcoming San Francisco event has been tremendous," reported Sharon O'Reilly, president & CEO of Medtech Insight. "We have a very full program planned, with 55 companies confirmed thus far to present, representing medical device innovations in all the major surgical markets. And, the majority are making their first appearance at an In3 conference. Our San Francisco In3 conferences are always a huge draw for medtech investment firms as well as all the major medical device companies."

Among the presenting companies confirmed for In3 San Francisco (see http://www.medtechinsight.com/in3-11.html for an updated listing) include: Acoustic MedSystems, Acta Vascular Systems, Advanced BioSensors, Affinergy, Alsius, ALung Technologies, Alveolus, American Medical Bio Care, Audiomedix, BioCare Systems, Bioenergy, Bioheart, BioniCare Medical Technologies, BrainZ Instruments, Celleration, CeraPedics, Chemel, CHF Technologies, CVAC Systems, DEGIMA Medical, Diabetech, Doxa, Duke Empirical, Dyansys, Everest Biomedical Instruments, FlowCardia, Gamida-Cell, Gene Express, Glucon Medical, ImageGuide, Kahn Medical Devices, Matryx Group, MicroMRI, MR Instruments, NeoMedix, Novare Surgical Systems, NovoStent, OsteoResorb, Pathway Medical Technologies, PhiloMetron, Pindi Products, PneuMedics, pSivida, Quantum Dot, Quantum Orthopedics, Replication Medical, Rheologics, Rhythm Technologies, SmokeSignals, Spinemed, Thermoceps, Unilead International, Xillix Technologies, Xoft microTube, and ZARS. Visit http://www.medtechinsight.com/in3-11.html for an updated list of presenting companies, and other conference details.

Mir A. Imran, inventor, entrepreneur and founder of numerous well-known medical device companies, including PercuSurge, Physiometrix, Cardiac Pathways, and Intella Interventional Systems, will kick off the two-day event with his keynote presentation entitled "Experiences in Building Companies from an Entrepreneurial and Investor Perspective." The event will also feature a talk from Kevin J. Wasserstein, Principal at Versant Ventures, entitled "Medtech Investing in 2004," and a presentation by Kevin M. Quinley, Senior Vice President of Risk Services at Medmarc Insurance Group, entitled "When Bad Things Happen to Good Companies: Preserving Your Financial Health in Product Liability Crises."

The San Francisco conference will also feature two informative industry panel discussions, one entitled "Preparing Your Medical Technology for Financing," hosted by Dorsey & Whitney, LLP, and the second, "Medtech Start-ups from Creation to Exit: What Does it Take?", an interactive session moderated by David Cassak, managing partner at Windhover Information, Inc.

In attendance at In3 San Francisco will be senior executives from many of the leading medical device and healthcare investment firms, including: Abbott Laboratories, Affinity Capital Management, Bay City Capital Partners, Boston Scientific, C.R. Bard, Datascope, Edwards Lifesciences, Ethicon Endo-Surgery, GE Medical Systems, Guidant, Interwest Partners, Johnson & Johnson, Kaiser Permanente Ventures, Kimberly-Clark, KPMG Corporate Finance, Medtronic, Morgan Stanley Venture Partners, Philips Medical Systems, Spray Venture Partners, St. Jude Medical, Stryker, Terumo, Tyco Healthcare, Versant Ventures, and W.L. Gore, to name only a few (see http://www.medtechinsight.com/pastattendees.html for a listing of past attending companies).

To register to attend this important event, call Medtech Insight at 949-219-0150, or 888-290-2225 toll-free in the United States, or register on the Medtech Insight Web site, at http://www.medtechinsight.com/in3-11.html. Through Friday, April 30 only, attendees registering for the conference can save $200 off the $1,395 registration fee.

Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry. The company publishes analyses of medtech markets through its Market & Technology Reports group, offers custom consulting and market research, and holds "Investment In Innovation" conferences several times a year. To register for the San Francisco conference or for more information on Medtech Insight, please call 949-219-0150 or 888-290-2225 toll-free in the United States, fax [phone], e-mail [e-mail], or visit http://www.medtechinsight.com/in3-11.html. Visit the company's Web site at www.medtechinsight.com to read more about In3 conferences, view tables of contents for published and upcoming reports, and download a sample issue of the "medtech insight" newsletter.